Anhui Anke Biotechnology Research - aVenture Research
Anhui Anke Biotechnology
Anhui Anke Biotechnology, a Chinese biopharmaceutical group, develops genetic-engineering drugs, diagnostics and precision medicine, with self-developed Ansomone and Anterferon.
How does it win customers, and through which channels?
AnkeBio wins customers through direct reach: more than 40 regional offices spread across China carry its products to buyers in sales networks covering more than 30 Chinese provinces, while international cooperation has developed quickly.
In June 2026, AnkeBio attended CPhI China 2026 in Shanghai and brought its products to the event.
2Product Overview
What does the product do for its buyer, and how is it delivered?
Anhui Anke Biotechnology centers its offering on a self-developed biopharmaceutical line, including Human Growth Hormone (Ansomone), a series of Recombinant Human Interferon alpha 2b products (Anterferon), and a MAR Kit for Anti-sperm Antibody.
Anhui Anke Biotechnology develops, produces, and markets pharmaceuticals spanning genetic engineering products, diagnostic products, precision medicine, polypeptide APIs, biochemistry, and traditional Chinese medicines. Its product menu lists an Ansomone pre-filled syringe form and a recombinant human type III collagen (rhColIII) product. Production facilities hold GMP and ISO9001 certification.
